ML-9

ML-9
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T16104-5mg 5 mg

7 - 10 business days*

33.00€
TGM-T16104-1mL 1 ml

7 - 10 business days*

36.00€
TGM-T16104-10mg 10 mg

7 - 10 business days*

49.00€
TGM-T16104-25mg 25 mg

7 - 10 business days*

91.00€
TGM-T16104-50mg 50 mg

7 - 10 business days*

134.00€
TGM-T16104-100mg 100 mg

7 - 10 business days*

200.00€
 
Description: ML-9 suppresses MLCK, PKA, and PKC activity with Ki values of 4, 32, and 54 µM,... more
Product information "ML-9"
Description: ML-9 suppresses MLCK, PKA, and PKC activity with Ki values of 4, 32, and 54 µM, respectively. ML-9 is a selective and effective inhibitor of Akt kinase, inhibits myosin light-chain kinase (MLCK), and stromal interaction molecule 1 (STIM1) activity. ML-9 causes autophagy by stimulating autophagosome formation and inhibiting their degradation. Target: Akt, Myosin. Smiles: Cl.Clc1cccc2c(cccc12)S(=O)(=O)N1CCCNCC1. References: Ito S, et al. ML-9, a myosin light chain kinase inhibitor, reduces intracellular Ca2+ concentration in guinea pig trachealis.Eur J Pharmacol. 2004 Feb 23,486(3):325-33.
Supplier: TargetMol
Supplier-Nr: T16104

Properties

MW: 361.29 D
Formula: C15H18Cl2N2O2S

Database Information

CAS : 105637-50-1| Matching products

Handling & Safety

Storage: -20°C
Shipping: +20°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "ML-9"
Write a review
or to review a product.
Viewed